EUVIMEDEUVIMED entdecken
Crossref

Serotonergic antidepressant use following positive airway pressure initiation

Nicholas T Vozoris, Jin Luo, Peter C Austin, Clodagh M Ryan

Sleep Medicine · 2026-08 · 144 · 108942

DOI: 10.1016/j.sleep.2026.108942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep Medicine, 2026-08. Verfasst von Nicholas T Vozoris und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, St. Michael's Hospital, Toronto, Ontario, Canada; Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael'…. Hauptthemen laut MEDLINE: Antidepressive Agents, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Depression. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Cancer Care Ontario, Institut canadien d'information sur la santé, Ministry of Long-Term Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Some previous research has demonstrated that treatment of obstructive sleep apnea (OSA) improves depression and anxiety symptoms, but whether treating OSA translates into a reduction in antidepressant drug use is uncertain. We evaluated the impact of initiating incident positive airway pressure (PAP) therapy on serotonergic antidepressant discontinuation among chronic drug users. METHODS We used a population-based, retrospective cohort design, analyzing Ontario health administrative data from January 1, 2010-December 31, 2019. Ontarians ages 65 years of age and older, who were chronic serotonergic antidepressant users, were included. Our main analysis evaluated the association between new PAP receipt and serotonergic antidepressant drug discontinuation between 6 and 12 months post-PAP initiation. To minimize confounding, we used propensity score matching to account for potential differences in 49 relevant covariates between new and non-PAP users. RESULTS We identified 181,639 chronic serotonergic antidepressant users, of whom 6.3% newly received PAP. In our matched cohort, we found that new vs. non-PAP users had significantly lower rate of serotonergic antidepressant discontinuation at the 6-12 month mark (6.2% vs. 9.0%, relative risk [RR] 0.69, 95% confidence interval [CI] 0.62-0.77). Similar findings were observed when considering a more distant follow-up period of 12-18 months post-PAP initiation (8.4% vs. 12.6%, RR 0.67, 95% CI 0.61-0.73). CONCLUSIONS Relative to non-PAP use, new PAP receipt was associated with significantly lower rates of serotonergic antidepressant discontinuation among chronic drugs users. Further research is required to determine the causation of this unanticipated finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsSleep Apnea, ObstructiveContinuous Positive Airway PressureDepressionHumansFemaleMaleRetrospective StudiesOntarioAged

Stichwörter der Autor:innen

AntidepressantsHealth services researchSleep breathing disorder treatment

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Division of Respirology, St. Michael's Hospital, Toronto, Ontario, Canada; Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada; Department of Medicine, Universi…
  • ICES, Toronto, Ontario, Canada.
  • ICES, Toronto, Ontario, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Respirology, University Health Network, Toronto, Ontario, Canada.

Förderung

  • Cancer Care Ontario
  • Institut canadien d'information sur la santé
  • Ministry of Long-Term Care
  • Institute for Clinical Evaluative Sciences
  • Ministry of Health, Uganda
  • Ontario Ministry of Health and Long-Term Care

Zitieren

APA

Vozoris, N. T., Luo, J., Austin, P. C., & Ryan, C. M. (2026). Serotonergic antidepressant use following positive airway pressure initiation. Sleep Medicine, 144, 108942. https://doi.org/10.1016/j.sleep.2026.108942

Vancouver

Vozoris NT, Luo J, Austin PC, Ryan CM. Serotonergic antidepressant use following positive airway pressure initiation. Sleep Medicine. 2026;144:108942. doi:10.1016/j.sleep.2026.108942

BibTeX
@article{Vozoris2026,
  author = {Vozoris, Nicholas T and Luo, Jin and Austin, Peter C and Ryan, Clodagh M},
  title = {Serotonergic antidepressant use following positive airway pressure initiation},
  journal = {Sleep Medicine},
  year = {2026},
  volume = {144},
  pages = {108942},
  doi = {10.1016/j.sleep.2026.108942}
}
Kostenlos starten →